MktsMarkets

National Health Investors, Inc.
NYSE: NHIKey statistics
NHI News
Stories mentioning NHI from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 37,060 | 30,729 | 21,177 | 14,217 | 13,939 | 14,004 | 13,771 | 13,390 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | 78,025 | 69,791 | 57,555 | 55,607 | 56,008 | 54,186 | 54,804 | 51,771 |
| Operating Income (Loss) | ||||||||
| Interest Income | ||||||||
| Interest Expense | 15,040 | 14,264 | 13,766 | 15,001 | 14,337 | 15,241 | 14,939 | 14,854 |
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | 40,102 | 38,163 | 32,862 | 36,987 | 34,165 | 43,242 | 28,540 | 35,256 |
| Earnings Per Share (Basic) | 0.83 | 0.81 | 0.69 | 0.79 | 0.75 | 0.99 | 0.66 | 0.81 |
| Earnings Per Share (Diluted) | 0.82 | 0.81 | 0.69 | 0.79 | 0.74 | 0.98 | 0.65 | 0.81 |
| Weighted Average Shares Outstanding (Basic) | 48,324 | 46,875 | 47,433 | 46,692 | 45,720 | 43,845 | 43,476 | 43,397 |
| Weighted Average Shares Outstanding (Diluted) | 48,548 | 47,052 | 47,624 | 46,822 | 45,879 | 44,103 | 43,987 | 43,564 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About NHI
National Health Investors, Inc. (NYSE: NHI) is a stock listed on the New York Stock Exchange under the ticker symbol NHI. It last traded at $61.39 (Nov 19, 2026, 4:00 PM ET), down 1.7% on the day. That gives National Health Investors a market capitalisation of $3.0B and a price-to-earnings ratio of 18.3.
Over the past 52 weeks NHI has traded between $59.05 and $91.38.
Revenue for the quarter ended Mar 31, 2026 was $37.1M; net income $40.1M. Revenue was up 166% from $13.9M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $37.1M | $40.1M | 108.2% |
| Dec 31, 2025 | $30.7M | $38.2M | 124.2% |
| Sep 30, 2025 | $21.2M | $32.9M | 155.2% |
| Jun 30, 2025 | $14.2M | $37.0M | 260.2% |
From National Health Investors’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…